Medical & Biological Laboratories Co., Ltd.

Equities

4557

JP3131450003

MBL International Corporation announced that it expects to receive funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.

March 13, 2016

MBL International Corporation announced a private placement of 5,500,000 shares on March 14, 2016. The transaction will include participation from new investor JSR Micro, Inc. and existing investor Medical & Biological Laboratories Co., Ltd. whose stake in the transaction will decrease to 49% after the transaction. The transaction is expected to close by April 1, 2016.

Latest news about Medical & Biological Laboratories Co., Ltd.

Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanese Customers	22-05-12	CI
JSR Corporation acquired remaining 7.27% stake in Medical & Biological Laboratories Co., Ltd. for ¥1.7 billion.	20-12-17	CI
JSR Corporation completed the acquisition of an additional 41.91% stake in Medical & Biological Laboratories Co., Ltd. for ¥9.5 billion.	20-12-09	CI
JSR Corporation made an offer to acquire the remaining 49.2% stake in Medical & Biological Laboratories Co., Ltd. for ¥11.2 billion.	20-10-26	CI
Medical & Biological Laboratories Co., Ltd. Starts the Sale of A Test Kit (For Research Use Only) for Measuring SARS-CoV-2 Neutralizing Antibodies	20-10-15	CI
Medical & Biological Laboratories Co., Ltd. Announces “MEBRIGHTTM SARS-CoV-2 Kit” Was Approved with Marketing Authorization in Japan for the Detection of Novel Coronavirus “SARS-CoV-2”	20-05-21	CI
Medical and Biological Laboratories Co., Ltd. Concludes License Agreement with China National Biotec Group Co., Ltd	20-05-10	CI
Medical & Biological Laboratories Co., Ltd. Launches New ELISA-Based Companion Diagnostic Kit for Spinal Muscular Atrophy	20-05-08	CI
Pmt Corporation Co. Ltd. cancelled the acquisition of Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others.	17-09-25	CI
MEDICAL & BIOLOGICAL LABORATORIES Co., Ltd. Enters into Collaboration Agreement with the p53 Laboratory	17-05-22	CI
Pmt Corporation Co. Ltd. agreed to acquire Lifetech Co., Ltd from Medical & Biological Laboratories Co., Ltd. and others for ¥0.07 million.	16-09-25	CI
MBL International Corporation announced that it has received funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.	16-04-20	CI
MBL International Corporation announced that it expects to receive funding from JSR Micro, Inc., Medical & Biological Laboratories Co., Ltd.	16-03-13	CI
Chiome Bioscience Inc. acquired remaining 47.1% stake in LivTech Inc. from Medical & Biological Laboratories Co., Ltd., KSP Inc., Kouji Nakamura, Hiroyuki Yanai and 3 other individuals.	15-03-13	CI
JSR Corporation completed the acquisition of 13.88% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.2 billion.	15-03-10	CI
JSR Corporation offered a take overbid to acquire 17.9% stake in Medical & Biological Laboratories Co., Ltd. for ¥2.8 billion.	15-02-08	CI
Medical & Biological Laboratories, Co., Ltd. Opens MBL Europe Office in Diegem, Belgium	15-01-26	CI
Medical & Biological Laboratories Co., Ltd. cancelled the acquisition of histopathology examination businesses of Histo Science Laboratory Co., Ltd.	14-07-04	CI
Medical & Biological Laboratories Co., Ltd. cancelled the acquisition of remaining 91.3% stake in ACTGen, Inc. from Toshieki Kajikawa and other shareholders.	14-01-21	CI
Closed Merger/Acquisition Transaction â€“ Target: LivTech Inc.; Buyer(s): Chiome Bioscience Inc.; Seller(s): JAFCO Incubation No. 2 Venture Capital Investment Limited Partnership, KSP Inc., MBL Venture Capital Co., Ltd., Medical & Biological Laboratories Co., Ltd., ReqMed Venture Capital, Yokohama Capital Co. Ltd.; Transaction Size: ¥87.75 mm	13-12-24	CI
Announced Merger/Acquisition Transaction â€“ Target: LivTech Inc.; Buyer(s): Chiome Bioscience Inc.; Seller(s): JAFCO Incubation No. 2 Venture Capital Investment Limited Partnership, KSP Inc., MBL Venture Capital Co., Ltd., Medical & Biological Laboratories Co., Ltd., ReqMed Venture Capital, Yokohama Capital Co. Ltd.; Transaction Size: ¥87.75 mm	13-12-15	CI
New Histo Science Laboratory Co., Ltd. announced that it has received ¥10 million in funding from Medical & Biological Laboratories Co., Ltd.	13-07-19	CI
Medical & Biological Laboratories Co., Ltd. entered into business transfer contract to acquire histopathology examination businesses of Histo Science Laboratory Co., Ltd. for approximately ¥150 million.	13-07-04	CI
New Histo Science Laboratory Co., Ltd. announced that it expects to receive ¥190 million in funding from Medical & Biological Laboratories Co., Ltd.	13-05-14	CI
Medical & Biological Laboratories Co., Ltd. announced that it has received ¥4.5 billion in funding from JSR Corp.	13-03-29	CI

Chart Medical & Biological Laboratories Co., Ltd.

Duration

Period

Chart Medical & Biological Laboratories Co., Ltd.

More charts

Company Profile

MEDICAL&BIOLOGICAL LABORATORIES CO., LTD. is a Japan-based company engaged in the research and development of clinical test drugs and basic research reagents, mainly for autoimmune diseases. The Company operates through two business segments. The Reagent segment is divided into the clinical diagnostics business and the life science translational research (LSTR) business. The main business is the research, development, manufacture and sales of clinical diagnostics and reagents related to basic research. This segment also sells related equipment and instruments, develops genetic test agents, prepares pathological specimens, and contracts for pathological diagnosis. The Investment segment is involved in the investment and cultivation of venture companies through venture capital funds.

Sector

More about the company